Literature DB >> 21909931

Humanized mice for studying human leukocyte integrins in vivo.

Sang-Soo Kim1, Priti Kumar, Chunting Ye, Premlata Shankar.   

Abstract

Humanized mice have recently emerged as powerful translational animal models for studying human hematopoiesis, immune interactions, and diseases of the human immune system. Several important advances in the humanized mouse technology have been reported over the last few years, thereby resulting in improved engraftment, high levels of human chimerism, and sustained human hematopoiesis. This chapter describes the detailed procedures for generating various humanized mouse models including hu-PBL, hu-HSC, and BLT models and discusses considerations for choosing the appropriate model system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21909931      PMCID: PMC4310724          DOI: 10.1007/978-1-61779-166-6_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

Review 1.  Humanized mice in translational biomedical research.

Authors:  Leonard D Shultz; Fumihiko Ishikawa; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2007-02       Impact factor: 53.106

2.  Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1.

Authors:  Michael W Melkus; Jacob D Estes; Angela Padgett-Thomas; Joel Gatlin; Paul W Denton; Florence A Othieno; Anja K Wege; Ashley T Haase; J Victor Garcia
Journal:  Nat Med       Date:  2006-10-22       Impact factor: 53.440

3.  Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.

Authors:  Ping Lan; Noriko Tonomura; Akira Shimizu; Shumei Wang; Yong-Guang Yang
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

4.  Animal models of HIV-1 disease.

Authors:  J M McCune
Journal:  Science       Date:  1997-12-19       Impact factor: 47.728

5.  Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model.

Authors:  Hidefumi Hiramatsu; Ryuta Nishikomori; Toshio Heike; Mamoru Ito; Kimio Kobayashi; Kenji Katamura; Tatsutoshi Nakahata
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

6.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

Authors:  Fumihiko Ishikawa; Masaki Yasukawa; Bonnie Lyons; Shuro Yoshida; Toshihiro Miyamoto; Goichi Yoshimoto; Takeshi Watanabe; Koichi Akashi; Leonard D Shultz; Mine Harada
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

7.  Functional human T lymphocyte development from cord blood CD34+ cells in nonobese diabetic/Shi-scid, IL-2 receptor gamma null mice.

Authors:  Takashi Yahata; Kiyoshi Ando; Yoshihiko Nakamura; Yoshito Ueyama; Kazuo Shimamura; Norikazu Tamaoki; Shunichi Kato; Tomomitsu Hotta
Journal:  J Immunol       Date:  2002-07-01       Impact factor: 5.422

8.  Systemic leukocyte-directed siRNA delivery revealing cyclin D1 as an anti-inflammatory target.

Authors:  Dan Peer; Eun Jeong Park; Yoshiyuki Morishita; Christopher V Carman; Motomu Shimaoka
Journal:  Science       Date:  2008-02-01       Impact factor: 47.728

9.  Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1.

Authors:  Dan Peer; Pengcheng Zhu; Christopher V Carman; Judy Lieberman; Motomu Shimaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

10.  Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.

Authors:  Paul W Denton; Jacob D Estes; Zhifeng Sun; Florence A Othieno; Bangdong L Wei; Anja K Wege; Daniel A Powell; Deborah Payne; Ashley T Haase; J Victor Garcia
Journal:  PLoS Med       Date:  2008-01-15       Impact factor: 11.069

View more
  5 in total

1.  From in silico hit to long-acting late-stage preclinical candidate to combat HIV-1 infection.

Authors:  Shalley N Kudalkar; Jagadish Beloor; Elias Quijano; Krasimir A Spasov; Won-Gil Lee; José A Cisneros; W Mark Saltzman; Priti Kumar; William L Jorgensen; Karen S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-26       Impact factor: 11.205

2.  Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection.

Authors:  Mark S Ladinsky; Pradeep D Uchil; Xaver Sewald; Jagadish Beloor; Ruoxi Pi; Christin Herrmann; Nasim Motamedi; Thomas T Murooka; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Thorsten R Mempel; Pamela J Bjorkman; Priti Kumar; Walther Mothes
Journal:  Science       Date:  2015-10-01       Impact factor: 47.728

3.  Adenovirus-Vectored Broadly Neutralizing Antibodies Directed Against gp120 Prevent Human Immunodeficiency Virus Type 1 Acquisition in Humanized Mice.

Authors:  Shan Liu; Andrew Jackson; Jagadish Beloor; Priti Kumar; Richard E Sutton
Journal:  Hum Gene Ther       Date:  2015-08-11       Impact factor: 5.695

4.  Heart bailout by cell therapy: introducing an acceptable test for comparing cell accountability.

Authors:  Paolo Madeddu
Journal:  Stem Cell Res Ther       Date:  2012-08-14       Impact factor: 6.832

Review 5.  Application of Humanized Mice in Immunological Research.

Authors:  Wenwei Tu; Jian Zheng
Journal:  Methods Mol Biol       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.